-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Lyell Immunopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2019 to Q3 2025.
- Lyell Immunopharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 18.3M shares, a 42.6% increase year-over-year.
- Lyell Immunopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 261M shares, a 4.18% increase from 2023.
- Lyell Immunopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 251M shares, a 1.58% increase from 2022.
- Lyell Immunopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 247M shares, a 81.8% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)